Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health.
REVOLUTION Medicines
19 followers
Summit Therapeutics
8 followers
C4 Therapeutics
8 followers
Stemline Therapeutics
4 followers
Pendulum
4 followers
Viridian Therapeutics
2 followers
RayzeBio
2 followers
Bicara Therapeutics
2 followers
Boyce Thompson Institute
2 followers
Tenaya Therapeutics
2 followers
Eikon Therapeutics
4 followers
GreenLight Biosciences
1 follower